期刊文献+

厄贝沙坦和咪达普利对早期自发性高血压大鼠血尿酸和血脂代谢的影响 被引量:3

Effects of irbesartan and imidapril on serum uric acid and lipids in early spontaneously hypertensive rats
原文传递
导出
摘要 目的 :检测早期雄性自发性高血压大鼠 (SHR)血清尿酸 (UA)、总胆固醇 (TC)、甘油三酯 (TG)、高密度脂蛋白胆固醇 (HDL C)和低密度脂蛋白胆固醇 (LDL C)的水平 ;并观察抗高血压药厄贝沙坦和咪达普利对血UA和血脂代谢的影响。方法 :将SHR随机分为 3组 ,咪达普利组给含咪达普利的水 3mg·kg-1·d-1;厄贝沙坦组给含厄贝沙坦的水 5 0mg·kg-1·d-1;SHR对照组 ,另设雄性同龄WistarKyoto(WKY)正常血压对照组。实验于 3个月后停药 ,测体重和血压 ,检测血清UA、TC、TG、HDL C和LDL C。结果 :与WKY组比较 ,SHR组UA、TG和LDL C显著增高 ;厄贝沙坦组UA、TG显著降低 ,与咪达普利组比较差异有显著性意义 ;与SHR组比较 ,咪达普利组和厄贝沙坦组血压均显著降低。结论 :高血压早期已经存在着高UA血症和血脂异常等代谢综合征的临床征象 。 Objective:To assess the effects of imidarpril and irbesartan on serum uric acid (UA), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL C) and low density lipoprotein cholesterol (LDL C) in early spontaneously hypertensive rats (SHRs).Methods:The male SHRs were divided into four groups (n=10, each), imidapril group (3 mg·kg -1 ·d -1 ), irbesartan group (50 mg·kg -1 ·d -1 ) and SHR control and age matched male Wistar Kyoto (WKY) control group. After three months, serum UA, TC, TG, HDL C and LDL C were determined in alll rats.Results:In SHR group, UA (P< 0.05 ), TG and LDL C (P< 0.01 )were significantly higher than that in WKY group. As compared to SHR group, the blood pressure (SP) in imidapril and irbesartan group were significantly decreased (P< 0.01 ); imidapril significantly decreased LDL C (P< 0.01 ); irbesartan lowered UA (P< 0.05 ) and TG (P< 0.01 ).Conclusion:Metabolic syndrome (such as hyperuricemia and dyslipidemia) exists in the early period of primary hypertension. Irbesartan can reduce not only serum TG but also serum UA. It suggests that irbesartan has the effects of antiatherosclerosis and renal protection.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2002年第9期450-451,共2页 Journal of Clinical Cardiology
关键词 厄贝沙坦 咪达普利 自发性高血压 大鼠 血尿酸 血脂代谢 Irbesartan Imidapril Uric Acid Lipids Hypertension
  • 相关文献

参考文献3

  • 1刘国仗,王兵.重视对高血压危险因素的综合控制[J].中华心血管病杂志,2001,29(4):193-193. 被引量:76
  • 2吴锡桂 余振球 等.高血压的定义及分类.实用高血压学(第2版)[M].北京:科学出版社,2000.3-16.
  • 3王海燕 黄峻.高血压的危害.高血压现代治疗[M].南京:江苏科学技术出版社,2000.1-28.

共引文献75

同被引文献46

  • 1葛淑兰,田景振.淫羊藿及其有效成分的药理研究进展[J].中国药师,2005,8(6):462-464. 被引量:44
  • 2姜洪,李云良.抗高血压药物对血脂代谢的影响[J].福建医药杂志,1990,12(1):41-42. 被引量:2
  • 3王强.莫索尼定不影响血脂及低密度脂蛋白亚型[J].中国医学论坛报,2000,26(19):14-14.
  • 4Macleod MJ, Mclay J. Drug treatment of hypertension complicating diabetes mellitus [ J ]. Drugs, 1998, 56(2): 189-202.
  • 5Tamasawa N, Matsui J, Ogawa Y, et al. Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension [ J ]. Diabetes Complications, 2000,14(3) :135-139.
  • 6Totsuka M, Miyashita Y, Ito Y, et al. The effect of celiprolol hydrochloride for lipid metabolism-especially for the low density lipoprotein particle size [ J ].Nippon Ronen Igakkai Zasshi, 2001,38(3) :352-359.
  • 7Noguchi N, Nishino K, Niki E. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation[ J ]. Biochem Pharmacol, 2000, 59(9) :1069-1076.
  • 8Pressel S, Davis BR, Louis G T, et al. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ( ALLHAT) [J]. Control Clin Trials, 2001,22(6): 674-686.
  • 9Ahaneku JE, Sakata K, Urano T, et al. Influence of baseline values on lipids,lipeproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients [ J ]. Pharmacol Res, 2001,41 ( 1 ): 75-79.
  • 10Ashida T. Treatment of hypertension with dyslipidemia [ J ]. Nippon Rinsho,2001,59 (5) :978-982.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部